Becton Dickinson and Company (BDX)

241.12
-0.65(-0.27%)
After Hours
239.65
-1.47(-0.61%)
- Real-time Data
  • Volume:
    840,256
  • Day's Range:
    240.64 - 243.32
  • 52 wk Range:
    215.90 - 269.06

BDX Overview

Prev. Close
241.77
Day's Range
240.64-243.32
Revenue
18.81B
Open
241.58
52 wk Range
215.9-269.06
EPS
5.37
Volume
840,256
Market Cap
68.48B
Dividend (Yield)
3.64
(1.51%)
Average Vol. (3m)
1,044,654
P/E Ratio
44.97
Beta
0.565
1-Year Change
-5.98%
Shares Outstanding
284,014,905
Next Earnings Date
Aug 03, 2023
What is your sentiment on Becton Dickinson?
or
Market is currently closed. Voting is open during market hours.

Becton Dickinson and Company Company Profile

Becton Dickinson and Company Company Profile

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Read More

Analyst Price Target

Average287.42 (+19.20% Upside)
High304.00
Low260.00
Price241.12
No. of Analysts12
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellBuy
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
  • Can someone tell me the difference between this stock and AMBU(danish company). Becides the fact that AMBU is valued 1/5 of BDX…
    0
    • anyone an idea for a target?
      0
      • $240
        0
    • https://www.fool.com/investing/2021/02/27/these-3-stocks-big-winners-from-president-biden/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article
      0
      • Last chance to get in , DPA will give a big boost in a few weeks.
        1
        • Rajeesh Raju good luck
          0
        • Lode Schepershttps://www.nasdaq.com/articles/becton-dickinson-gets-eua-for-new-diagnostic-test-2021-02-14
          0
        • Rajeesh Raju Thank you very much. Succes!
          0
      • bye bye b d x you stepped on Elon Musk toes
        2
        • what happened ?
          0
      • https://www.biospace.com/article/releases/cardiff-oncology-prices-public-offering-sep-30-2020/
        0
        • 300$ by end of 2020
          1
          • We need to see at least 230 before its worth getting into.
            2
            • insane earnings, insane share price, insane P/E ratio
              0
              • P/E isn't insane, 91 is without NRI, forward P/E is 20. At 15 it would be a good entry point but the price would have to be $180.
                0
            • . I want to know if this asset comes in at 192 this week? What do you guys think?
              0
              • I would pull the trigger at $180 with a forward P/E of 15.
                0